REFERENCES
- Griendling KK, Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998; 132: 9–15.
- Miller Jr FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82: 1298–1305.
- Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 1989; 264: 21340–21345.
- Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1986; 77: 757–761.
- Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 1992; 5: 834–842.
- Reilly PM, Schiller HJ, Bulldey GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991; 161: 488–503.
- Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982; 79: 7634–7638.
- Strain P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995; 15: 2032–2036.
- Marklund SL. Expression of extracellular superoxide dismutase by human cell lines. Biochem J1990; 266: 213-219.
- Takatsu H, Tasaki H, Kim FIN et al. Overexpression of EC-SOD suppresses endothelial-cell-mediated LDL oxidation. Biochem Biophys Res Commun 2001; 285: 84–91.
- Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann NY Acad Sci 1999; 892: 146–154.
- Pieper GM, Meier DA, Hager SR. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am J Physiol 1995; 269: H845–H850.
- Craven PA, Melhem MF, Phillips SL, DeRubertis FR. Overexpression of Cu2'/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 2001; 50: 2114–2125.
- Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 1992; 267: 6696–6701.
- Strain P, Marklund SL. Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. Am J Physiol 2001; 281: H1621–H1629.
- Adachi T, Hara H, Yamada H et al. Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis 2001; 159: 307–312.
- Folz RJ, Crapo JD. Extracellular superoxide dismutase (50D3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics 1994; 22: 162–171.
- Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H. Prolactin enhances CCAAT enhancer-binding protein-I3 (C/EB129) and peroxisome proliferator-activated receptor 7 (PPARy) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 2000; 14: 307–316.
- Hamm JK, El-Jack AK, Pilch PF, Farmer SR. Role of PPARy in regulating adipocyte differentiation and insulin-responsive glucose uptake. Ann NY Acad Sci 1999; 892: 134–145.
- Doppler W, Welte T, Philipp S. CCAAT/enhancer-binding protein isoforms 13 and 8 are expressed in mammary epithelial cells and bind to multiple sites in the I3-casein gene promoter. J Biol Chem 1995; 270: 17962–17969.
- Adachi T, Inoue M, Hara H, Maehata E, Suzuki S. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 2004; 181: 413–417.
- Zoccali C, Mallamaci F, Tripepi Get al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134–141.
- Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.
- Ouchi N, Kihara S, Arita Yet al. Novel modulator for endothelial adhesion molecules. Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–2476.
- Hirose H, Kawai T, Yamamoto Yet al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 2002; 51: 314–317.
- Maeda N, Takahashi M, Funahashi T et al. PPARy ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50:2094–2099.
- Saito K, Tobe T, Yoda M, Nakano Y, Choi-Miura N-H, Tomita M. Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP. Biol Pharm Bull 1999; 22: 1158–1162.
- Wu Z, Xie Y, Morrison RF, Bucher NLR, Farmer SR. PPARy induces the insulin-dependent glucose transport GLUT4 in the absence of C/EBPa during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 1998; 101: 22–32.
- Marldund SL, Nilsson P, Israelsson K, Schampi I, Peltonen M, Asplund K. Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 1997; 242: 5–14.
- Engstrom BE, Karlsson FA, Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clin Chem 1998; 44: 1289–1295.
- Isidori AM, Strollo F, More M et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000; 85: 1954–1962.
- Cavarape A, Feletto F, Mercuri F, Quagliaro L, Daman G, Ceriello A. High-fructose diet decreases catalase mRNA levels in rat tissues. J Endocrinol Invest 2001; 24: 838–845.
- Yamagishi S, Edelstein D, Du X-L, Kaneda Y, Guzmán M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276: 25096–25100.
- Sentman M-L, Jonsson LM, Marklund SL. Enhanced alloxan-induced I3-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase. Free Radic Biol Med 1999; 27: 790–796.